BAJAJ BROKING

Notification close image
No new Notification messages
card image
Euro Pratik Sales Ltd IPO
Apply for the Euro Pratik Sales Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

524572

PHARMAID

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Pharmaids Pharmaceuticals Share Price Update

As of the latest trading session, Pharmaids Pharmaceuticals share price is currently at ₹ 55.1, which is down by ₹ -1.67 from its previous closing. Today, the stock has fluctuated between ₹ 54.50 and ₹ 56.95. Over the past year, Pharmaids Pharmaceuticals has achieved a return of 36.64 %. In the last month alone, the return has been -8.03 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Pharmaids Pharmaceuticals fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    194.30

  • P/E Ratio (TTM)

    -19.99

  • Beta

    0.13

  • Book Value / share

    18.08

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    -4.36

info icon alternate text

Pharmaids Pharmaceuticals Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 1.12
Operating Expense 7.15
Net Profit -4.36
Net Profit Margin (%) -389.28
Earnings Per Share (EPS) -1.24
EBITDA -4.53
Effective Tax Rate (%) 23.37
Particulars MAR 2025 (Values in Cr)
Revenue 0.13
Operating Expense 4.92
Net Profit -3.06
Net Profit Margin (%) -2353.84
Earnings Per Share (EPS) -0.86
EBITDA -1.68
Effective Tax Rate (%) 19.04
Particulars DEC 2024 (Values in Cr)
Revenue 1.21
Operating Expense 3.06
Net Profit -1.59
Net Profit Margin (%) -131.40
Earnings Per Share (EPS) -0.45
EBITDA -1.73
Effective Tax Rate (%) 13.51
Particulars SEP 2024 (Values in Cr)
Revenue 0.83
Operating Expense 2.01
Net Profit -1.01
Net Profit Margin (%) -121.68
Earnings Per Share (EPS) -0.29
EBITDA -1.13
Effective Tax Rate (%) 15.12
Particulars JUN 2024 (Values in Cr)
Revenue 0.17
Operating Expense 1.94
Net Profit -1.62
Net Profit Margin (%) -952.94
Earnings Per Share (EPS) -0.46
EBITDA -1.71
Effective Tax Rate (%) 8.47
Particulars MAR 2025 (Values in Cr)
Revenue 2.34
Operating Expense 11.95
Net Profit -7.28
Net Profit Margin (%) -311.11
Earnings Per Share (EPS) -2.06
EBITDA -6.23
Effective Tax Rate (%) 15.25
Particulars MAR 2024 (Values in Cr)
Revenue 0.03
Operating Expense 6.91
Net Profit -4.95
Net Profit Margin (%) -16500.00
Earnings Per Share (EPS) -2.18
EBITDA -5.58
Effective Tax Rate (%) 18.71
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 9.91
Net Profit -7.56
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -5.86
EBITDA -9.89
Effective Tax Rate (%) 23.71
Particulars MAR 2022 (Values in Cr)
Revenue 3.94
Operating Expense 3.81
Net Profit 0.15
Net Profit Margin (%) 3.80
Earnings Per Share (EPS) 0.14
EBITDA 0.15
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 8.55
Operating Expense 8.49
Net Profit 0.09
Net Profit Margin (%) 1.05
Earnings Per Share (EPS) 0.09
EBITDA 0.13
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 16.82
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.36
EBITDA Margin -65.50
Particulars MAR 2024 (Values in Cr)
Book Value / Share 20.43
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.09
EBITDA Margin -81.54
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.31
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 8.44
ROE % 1.36
ROCE % 1.36
Total Debt to Total Equity 0.00
EBITDA Margin 3.81
Particulars MAR 2025 (Values in Cr)
Book Value / Share 18.09
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.39
EBITDA Margin -266.67
Particulars MAR 2024 (Values in Cr)
Book Value / Share 20.15
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.14
EBITDA Margin -18600.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.46
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 8.44
ROE % 1.36
ROCE % 1.36
Total Debt to Total Equity 0.00
EBITDA Margin 3.81
Particulars MAR 2021 (Values in Cr)
Book Value / Share 8.30
ROE % 0.82
ROCE % 0.82
Total Debt to Total Equity 0.00
EBITDA Margin 1.52
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.14
Total Assets 119.85
Total Liabilities 119.85
Total Equity 55.04
Share Outstanding 35267812
Price to Book Ratio 3.80
Return on Assets (%) -8.99
Return on Capital (%) -11.94
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 4.80
Total Assets 91.34
Total Liabilities 91.34
Total Equity 70.49
Share Outstanding 35267812
Price to Book Ratio 2.58
Return on Assets (%) -8.72
Return on Capital (%) -10.51
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 12.75
Total Assets 24.58
Total Liabilities 24.58
Total Equity 22.46
Share Outstanding 21443819
Price to Book Ratio 2.09
Return on Assets (%) -30.72
Return on Capital (%) -33.64
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.40
Total Assets 11.11
Total Liabilities 11.11
Total Equity 8.67
Share Outstanding 10268819
Price to Book Ratio 1.48
Return on Assets (%) 1.30
Return on Capital (%) 1.67
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.46
Total Assets 118.68
Total Liabilities 118.68
Total Equity 63.78
Share Outstanding 35267812
Price to Book Ratio 3.80
Return on Assets (%) -6.13
Return on Capital (%) -7.05
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.45
Total Assets 85.00
Total Liabilities 85.00
Total Equity 71.06
Share Outstanding 35267812
Price to Book Ratio 2.58
Return on Assets (%) -5.82
Return on Capital (%) -5.92
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 12.75
Total Assets 24.54
Total Liabilities 24.54
Total Equity 22.42
Share Outstanding 21486234
Price to Book Ratio 2.09
Return on Assets (%) -30.77
Return on Capital (%) -33.69
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.40
Total Assets 11.11
Total Liabilities 11.11
Total Equity 8.67
Share Outstanding 10268819
Price to Book Ratio 1.48
Return on Assets (%) 1.30
Return on Capital (%) 1.67
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.20
Total Assets 9.11
Total Liabilities 9.11
Total Equity 8.52
Share Outstanding 10268819
Price to Book Ratio 1.35
Return on Assets (%) 1.02
Return on Capital (%) 1.09
Particulars MAR 2025 (Values in Cr)
Net Income -17.27
Cash from Operations -13.92
Cash from Investing -12.02
Cash from Financing 23.35
Net change in Cash -2.65
Free Cash Flow -1.44
Particulars MAR 2024 (Values in Cr)
Net Income -15.62
Cash from Operations -10.61
Cash from Investing -74.99
Cash from Financing 77.65
Net change in Cash -7.95
Free Cash Flow 12.24
Particulars MAR 2023 (Values in Cr)
Net Income -9.90
Cash from Operations -4.01
Cash from Investing -4.94
Cash from Financing 21.30
Net change in Cash 12.34
Free Cash Flow -2.34
Particulars MAR 2022 (Values in Cr)
Net Income 0.14
Cash from Operations -0.25
Cash from Investing 0.46
Cash from Financing 0.00
Net change in Cash 0.20
Free Cash Flow -0.25
Particulars MAR 2025 (Values in Cr)
Net Income -8.58
Cash from Operations -7.72
Cash from Investing -18.90
Cash from Financing 24.63
Net change in Cash -1.99
Free Cash Flow 1.31
Particulars MAR 2024 (Values in Cr)
Net Income -6.08
Cash from Operations -3.44
Cash from Investing -72.50
Cash from Financing 65.65
Net change in Cash -10.29
Free Cash Flow 12.92
Particulars MAR 2023 (Values in Cr)
Net Income -9.90
Cash from Operations -4.01
Cash from Investing -4.94
Cash from Financing 21.31
Net change in Cash 12.35
Free Cash Flow -2.34
Particulars MAR 2022 (Values in Cr)
Net Income 0.14
Cash from Operations -0.25
Cash from Investing 0.46
Cash from Financing 0.00
Net change in Cash 0.20
Free Cash Flow -0.25
Particulars MAR 2021 (Values in Cr)
Net Income 0.08
Cash from Operations 0.40
Cash from Investing -0.22
Cash from Financing 0.00
Net change in Cash 0.17
Free Cash Flow 0.40
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 30.82 12.58 1.68 236.18 30.00 / 68.00
BLISS GVS PHARMA LTD 151.50 15.00 1.52 1599.41 105.05 / 190.65
CIPLA LTD 1558.25 23.34 4.03 125868.28 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 348.05 9.80 2.82 1024.35 219.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 30.82 16.75 4.87 236.18 30.00 / 68.00
AMRUTAJAN HEALTH LTD 760.10 40.30 6.72 2197.50 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9018.70 106.62 29.26 22546.75 6222.35 / 10653.05
BLISS GVS PHARMA LTD 151.50 22.65 1.51 1599.41 105.05 / 190.65

Pharmaids Pharmaceuticals Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
55.10 -2.94 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 58.00
  • 26 Days 60.60
  • 10 Days 59.00
  • 50 Days 61.40
  • 12 Days 59.30
  • 100 Days 62.20
  • 20 Days 60.20
  • 200 Days 61.80
57.27 PIVOT

First Support

55.88

First Resistance

58.75

Second Support

54.40

Second Resistance

60.14

Third Support

53.01

Third Resistance

61.62

RSI

35.32

ADX

12.46

MACD

-1.14

Williams % R

-80.38

Commodity Channel Index (CCI)

-199.92

Date

2025-09-16

Week

3594.00

Same Day

4648.00

Month

3554.00

1 Year

0.14

3 Year

0.12

Over 1 Month

-8.03%

down

Over 1 Year

36.64%

down

Over 3 Months

-1.84%

down

Over 3 Years

61.16%

down

Over 6 Months

-18.00%

down

Over 5 Years

64.92%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

Pharmaids Pharmaceuticals shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
94.85%
Promoter Holdings
5.14%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Shankarappanagaraja Vinaya Babu 7020854.0 (19.91%) Public Shareholding
Shreedhara Shetty 6010621.0 (17.04%) Public Shareholding
Gokaram Ramkrishna Balaji 3195815.0 (9.06%) Public Shareholding
Asian Hotels 2722258.0 (7.72%) Public Shareholding
Tumkur Trade Center Pvt Ltd 1568000.0 (4.45%) Public Shareholding
Venkata Rao Sadhanala 1523271.0 (4.32%) Shareholding of Promoter and Promoter Group
Venu Madhava Kaparthy 867281.0 (2.46%) Public Shareholding
Makam Sreevalli 780242.0 (2.21%) Public Shareholding
Balagangadhara Bidanagere Channathimmaiah 650000.0 (1.84%) Public Shareholding
Mini Manikantan 500000.0 (1.42%) Public Shareholding
Venkatesh Mahendra 438097.0 (1.24%) Public Shareholding
S Prasad 425201.0 (1.21%) Public Shareholding
Padmaja Kalyani Sadhanala 189146.0 (0.54%) Shareholding of Promoter and Promoter Group
Pilli Meena Kumari 56000.0 (0.16%) Shareholding of Promoter and Promoter Group
Viswa Prasad Sadhanala 19153.0 (0.05%) Shareholding of Promoter and Promoter Group
Surekha Prashant Dave 9159.0 (0.03%) Shareholding of Promoter and Promoter Group
B. Venkatswamy 6070.0 (0.02%) Shareholding of Promoter and Promoter Group
Kant Rao 7300.0 (0.02%) Shareholding of Promoter and Promoter Group
Sureshkumar 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Baghi Rao Pankaj Sadhanala 25.0 (0.0%) Shareholding of Promoter and Promoter Group
Maharani Maheshwari Sadhanala 25.0 (0.0%) Shareholding of Promoter and Promoter Group
Dadi Urmila 25.0 (0.0%) Shareholding of Promoter and Promoter Group
Sadhanalla Dara Kalyani 1000.0 (0.0%) Shareholding of Promoter and Promoter Group
Rangoori Kantham 1000.0 (0.0%) Shareholding of Promoter and Promoter Group
Uttam P Jain 1000.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

Pharmaids Pharmaceuticals corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Pharmaids Pharmaceuticals Share Price

Pharmaids Pharmaceuticals Limited, incorporated in March, 1989 at Hyderabad, Telangana are the suppliers of Quality Grade range of speciality chemicals, skin care, hospital care and generic products in the areas of Orthopedic, Neuro and Gastro etc. The technical team uses quality proven chemical compounds and standard processing methods maintaining proper hygiene standards. The Company is primarily engaged in business of manufacturing of Generics, Bulk Drugs in various forms like tablets, capsules, liquids and powders etc., in allopathic and herbal Ayurvedic and Natural drug formulation.

Emergent Bio Naturals Limited (EBNL) was amalgamated with the Company in 2019-20 and the Scheme of Amalgamation was effective on September 27, 2019. Pursuant to the Scheme, 69,05,734 Equity Shares were allotted to Shareholders of Emergent Bio Naturals Limited on November 27, 2019.

The Company acquired 25.5% stake as 1st tranche in Anugraha Chemicals, a Partnership Firm, registered under Karnataka Partnership Rules, 1954 on February 1, 2023.

Parent organization Indian Private
NSE symbol [-]
Founded 1989
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Pharmaids Pharmaceuticals Ltd?

Answer Field

Pharmaids Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 55.10 as on Sep 18 2025 12:47 PM.

What is the Market Cap of Pharmaids Pharmaceuticals Ltd Share?

Answer Field

The market cap of Pharmaids Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 194.30 as on Sep 18 2025 12:47 PM.

What is the 52 Week High and Low of Pharmaids Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Pharmaids Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 87.46 and ₹ 31.90.

What is 1 year return for Pharmaids Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 34.52%.

What is the P/E Ratio of Pharmaids Pharmaceuticals Ltd Share?

Answer Field

As on Sep 18 2025 12:47 PM the price-to-earnings (PE) ratio for Pharmaids Pharmaceuticals Ltd share is -19.99.

What is the PB ratio of Pharmaids Pharmaceuticals Ltd Share?

Answer Field

As on Sep 18 2025 12:47 PM, the price-to-book (PB) ratio for Pharmaids Pharmaceuticals Ltd share is 18.08.

How to Buy Pharmaids Pharmaceuticals Ltd Share?

Answer Field

You can trade in Pharmaids Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Pharmaids Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Pharmaids Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Pharmaids Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91